News & Press Releases

Mintz advised the underwriters in connection with Cogent Biosciences, Inc.’s concurrent public offerings of $345 million of common stock (the “Equity Offering”) and $230 million in aggregated principal amount of 1.625% convertible senior notes due 2031 (the “Convertible Notes Offering”).

Mintz advised Diamond Antenna and Microwave Corporation, a developer of advanced radio frequency and electro-mechanical solutions and a portfolio company of Artemis Capital Partners, on its acquisition of Antenna Associates, a developer of antenna systems for military and commercial applications. This transaction follows Mintz’s representation of Artemis in its 2024 acquisition of Diamond Antenna and Microwave Corporation.

Mintz advised the underwriter in connection with a $75 million registered direct offering by Precision BioSciences, Inc. 

Mintz advised the underwriters in connection with a $50 million follow-on offering by Eledon Pharmaceuticals.

Fiduciary News recently featured insights from Of Counsel Michelle Capezza examining how 401(k) plans are evolving amid a broader shift toward corporate paternalism in retirement planning. The piece discusses how employers are increasingly embedding lifetime income and guided-saving features to help workers achieve retirement readiness as traditional pensions decline.

Mintz advised the underwriter in connection with a $75 million underwritten offering by MoonLake Immunotherapeutics of 7,142,857 Class A ordinary shares at an offering price of $10.50 per share. The aggregate gross proceeds to MoonLake Immunotherapeutics from this offering were approximately $75 million before deducting underwriting discounts and commissions and other offering expenses.